Better-than-Expected Third Quarter Results
IDEX delivered better-than-expected results in the third quarter of 2025, with organic orders and sales increasing 5% and 10% respectively year-over-year.
Record Performance in Health & Science Technologies (HST) Segment
The HST segment reached a record high of $390 million, with organic revenue growth of 10% and a margin expansion of 120 basis points year-over-year.
Strong Order Growth in Fluid & Metering Technologies (FMT)
FMT saw an 8% increase in organic orders and a 4% increase in organic sales, driven by strong execution and pricing.
Successful Integration of Acquisitions
Recent acquisitions like Micro-Lam and Muon contributed positively, with Muon achieving profitability above the HST segment average.
Increased Shareholder Returns
IDEX repurchased $75 million in shares during the quarter, bringing the total to $175 million for the first three quarters of 2025.